June 22, 2009 – Englewood Hospital Home Health and Hospice Services said it entered into a business relationship with Cardiocom to provide advanced home telehealth technology to patients with chronic illnesses.
June 22, 2009 – BIOTRONIK GmbH today announced CE mark approval and first implantations of the new Evia cardiac pacemaker series, which features the only pacemaker with wireless, remote/home monitoring capabilities.
June 22, 2009 – Biosense Webster Inc. is showcasing the CARTO 3 System, an advanced three-dimensional imaging technology for use by electrophysiologists in treating cardiac arrhythmias this week at EUROPACE, the official Congress of the European Heart Rhythm Association.
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
June 22, 2009 –Jolife AB launched its second generation automated LUCAS Chest Compression System for use in cardiopulmonary resuscitation (CPR) of cardiac arrest patients in Europe and Canada.
June 22, 2009 – Patients with an implantable cardioverter defibrillator (ICD) have an ongoing risk of sudden incapacitation that might cause harm to others while driving a car, so driving restrictions are imposed making these recommendations an important guideline for patients.
June 22, 2009 – Surgeons from Arizona Heart Institute performed the first procedure in the U.S. Anaconda Phase II Study using the Vascutek Anaconda Stent Graft System, an investigational, minimally invasive treatment for abdominal aortic aneurysm (AAA).
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
June 19, 2009 - Increased utilization of advanced medical imaging, such as CT and MRI, between 1991 and 2004 improved life expectancy rates by a significant factor, actually greater than the increases in mortality caused by obesity over the same timeframe, according to a recent study conducted by Columbia University professor Frank Lichtenberg, Ph.D.
June 19, 2009 – Medtronic Inc. today said it received CE (Conformité Européenne) mark for the company's second-generation pacemaker designed, tested, approved for use as labeled with MRI machines, the Advisa DR MRI SureScan pacing system. The Advisa MRI SureScan pacing system currently is not available for sale in the U.S.
June 19, 2009 – HealthFrontier Inc., together with its technology partner, et medical devices SpA, Italy, yesterday introduced a new innovation in Web-enabled electrocardiogram (ECG) technology, the ecg@home, which is small enough to fit in the palm of a hand.
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
June 19, 2009 – The Society of Cardiovascular Computed Tomography (SCCT) is set to hold its fourth annual scientific meeting, July 16-19, 2009 in Orlando, Fla.
June 18, 2009 - Several definitions have been used to assess rates of contrast-induced nephropathy (CIN) in patients undergoing percutaneous coronary intervention (PCI), and a study this week in the American Journal of Cardiology (Vol. 103, Issues 12, pages 1,657-1,662, June 15, 2009), underlines the need to standardize these definitions.
June 18, 2009 – MedCentral Health System just launched Siemens new knowledge-driven, healthcare data-mining tool, Soarian Quality Measures, enabled by the REMIND (Reliable Extraction and Meaningful Inference from Non-structured Data) Platform.
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
June 18, 2009 - St. Jude Medical Inc. said today the FDA approved its Cool Point Irrigation Pump, used in conjunction with St. Jude Medical (SJM) open-irrigated ablation catheters, to supply a continuous flow of saline through the catheter’s inner lumen to cool the ablation electrode for more effective energy delivery.
June 18, 2009 - Berlin Heart Inc. said this week the FDA awarded it an Orphan Product Development Grant to support the ongoing investigational device exemption (IDE) study of the EXCOR Pediatric Ventricular Assist Device (VAD). The device received unconditional approval for investigational use in pediatric patients in the U.S. in October 2008. The grant will provide three years of support.
June 18, 2009 – Abbott this week initiated SPIRIT PRIME, a clinical trial to study the performance of the company's next-generation Xience PRIME Everolimus-Eluting Coronary Stent System, currently an investigational device, for the treatment of coronary artery disease.